|
SLC33A1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.520220E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.416900E-04 |
| Normal-vs-Stage2 |
3.422200E-01 |
| Normal-vs-Stage3 |
3.603000E-01 |
| Normal-vs-Stage4 |
7.546800E-01 |
| Stage1-vs-Stage2 |
4.191000E-01 |
| Stage1-vs-Stage3 |
1.895420E-01 |
| Stage1-vs-Stage4 |
1.231910E-02 |
| Stage2-vs-Stage3 |
8.223000E-01 |
| Stage2-vs-Stage4 |
2.851600E-01 |
| Stage3-vs-Stage4 |
3.269200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.860100E-03 |
| Normal-vs-AfricanAmerican |
4.715700E-02 |
| Normal-vs-Asian |
5.119200E-01 |
| Caucasian-vs-AfricanAmerican |
5.92299999999657E-05 |
| Caucasian-vs-Asian |
3.919200E-01 |
| AfricanAmerican-vs-Asian |
7.277000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.512600E-01 |
| Normal-vs-Female |
1.013780E-04 |
| Male-vs-Female |
6.593000E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.674000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.450300E-02 |
| Normal-vs-Age(61-80Yrs) |
4.870000E-02 |
| Normal-vs-Age(81-100Yrs) |
7.045400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.590800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.312800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.427000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.427800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.693200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.579000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.565900E-02 |
| Normal-vs-Grade 2 |
1.480020E-03 |
| Normal-vs-Grade 3 |
1.002590E-01 |
| Normal-vs-Grade 4 |
1.961610E-01 |
| Grade 1-vs-Grade 2 |
3.120000E-01 |
| Grade 1-vs-Grade 3 |
1.539370E-01 |
| Grade 1-vs-Grade 4 |
7.059600E-03 |
| Grade 2-vs-Grade 3 |
2.065200E-01 |
| Grade 2-vs-Grade 4 |
1.496270E-03 |
| Grade 3-vs-Grade 4 |
2.958000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.34450000524689E-08 |
| Normal-vs-ccB subtype |
9.813800E-01 |
| ccA subtype-vs-ccB subtype |
3.74499999999944E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.723000E-03 |
| Normal-vs-N1 |
8.849000E-01 |
| N0-vs-N1 |
4.727600E-01 |
|
|
